Title : Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study.

Pub. Date : 2015 Sep

PMID : 26296954






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Guadecitabine (SGI-110) is a novel hypomethylating dinucleotide of decitabine and deoxyguanosine resistant to degradation by cytidine deaminase. guadecitabine cytidine deaminase Homo sapiens